Search
for
Sort by
Research 781–810 of 1000+
- The hyperandrogenic-insulin-resistant acanthosis nigricans syndrome: therapeutic response
- Venous thromboembolism and women's health
- Contraception and the dermatologist
- Hair Loss and Hirsutism in the Elderly
- Alopecia.
- Body image, personality profiles and alexithymia in patients with polycystic ovary syndrome (PCOS)
- Comorbid conditions in lichen planopilaris: A retrospective data analysis of 334 patients
- The increasing incidence of frontal fibrosing alopecia. In search of triggering factors
- The pathophysiology of delayed ejaculation
- Sex and estrous cycle influence diazepam effects on anxiety and memory: Possible role of progesterone
- Contraceptive use in acne
- Management strategies for acne vulgaris
- Growth hormone-responsive alopecia in dogs
- Acute and Chronic Biotin Deficiencies in the Monkey (Macaca Mulatta)
- Diagnosis and Management of Polycystic Ovary Syndrome in Adolescent Girls
- Pemphigus vulgaris in only one of two monozygotic twins
- Menstrual Disorders
- Assessment, diagnosis and treatment of a patient with hirsutism
- Volatile organic compounds: A proinflammatory activator in autoimmune diseases
- COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
- A Holistic Approach to Antiaging as an Adjunct to Antiaging Procedures: A Review of the Literature
- Polycystic Ovary Syndrome in Adolescents
- A Perspective on the Evolving Landscape in Male Reproductive Medicine
- Endocrine and Reproductive Effects of Polycystic Ovarian Syndrome
- 17β-Estradiol Enhances Vascular Endothelial Growth Factor Production and Dihydrotestosterone Antagonizes the Enhancement via the Regulation of Adenylate Cyclase in Differentiated THP-1 Cells
- Die kontrazeptive Betreuung androgenisierter Frauen mit einem niedrig dosierten cyproteronacetathaltigen Einphasenpräparat
- Managing hair loss in midlife women
- Commentary: Unroofing for hidradenitis suppurativa, why and how
- Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor
- Women’s Health Care During the Perimenopause